We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Last summer, a team of scientists at Massachusetts General Hospital presented evidence showing that the tuberculosis vaccine bacillus Calmette-Guérin (BCG) restores beneficial immune cells in a way that could help treat Type 1 diabetes.